1. Endo thinks it has the financial flexibility to weather the storm of opioid settlements — Takeda acquires celiac-focused PvP Biologics — Iovance jumps on buyout rumors — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

DaVita

DaVita


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    0
    Views:
    106
  2. anonymous
    Replies:
    0
    Views:
    1,029
  3. anonymous
    Replies:
    0
    Views:
    1,269
  4. anonymous
    Replies:
    0
    Views:
    2,250
  5. Anonymous
    Replies:
    3
    Views:
    7,329

Thread Display Options

Loading...